News Summary

The Government of Canada has officially launched the Canadian Genomics Strategy, backed by $175.1 million CAD in federal funding over seven years. The strategy aims to advance commercialization and adoption in the genomics sector, supporting developments in personalized medicine, diagnostics, therapeutics, agriculture, and clean technology. Genome Canada will receive a significant portion of the funding, with $96 million over five years for its Genomic Applications Partnership Program. The initiative seeks to position Canada as a leader in genomics innovation, with additional investments from the Global Innovation Clusters program. This includes a $6.1 million investment in a project led by DNAstack to develop an AI-powered platform for global health data analysis. The strategy emphasizes the need for policies and incentives in life sciences to retain intellectual property and foster long-term growth in the sector.